Christopher J. Novosad

Array ( [id] => 7530444 [patent_doc_number] => 07842666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration' [patent_app_type] => utility [patent_app_number] => 10/327213 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 35797 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842666.pdf [firstpage_image] =>[orig_patent_app_number] => 10327213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711807 [patent_doc_number] => 20030171556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Beta-amyloid binding factors and inhibitors thereof' [patent_app_type] => new [patent_app_number] => 10/318302 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19127 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171556.pdf [firstpage_image] =>[orig_patent_app_number] => 10318302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083204 [patent_doc_number] => 20050048584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Method for detecting alzheimer\'s disease and differentiating alzheimer\'s disease from other demential diseases associated peptides and use thereof' [patent_app_type] => utility [patent_app_number] => 10/497073 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10897 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048584.pdf [firstpage_image] =>[orig_patent_app_number] => 10497073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468850 [patent_doc_number] => 20040102369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Transport of basic fibroblast growth factor across the blood brain barrier' [patent_app_type] => new [patent_app_number] => 10/307165 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14347 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102369.pdf [firstpage_image] =>[orig_patent_app_number] => 10307165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740156 [patent_doc_number] => 20030157525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Novel human G-protein coupled receptor, HGPRBMY31, and variants and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/305555 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 73378 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157525.pdf [firstpage_image] =>[orig_patent_app_number] => 10305555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7143702 [patent_doc_number] => 20050118586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Human cdnas and proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/495300 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108112 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118586.pdf [firstpage_image] =>[orig_patent_app_number] => 10495300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658229 [patent_doc_number] => 20030133874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Analytical method to evaluate animal models of neurofibrillary degeneration' [patent_app_type] => new [patent_app_number] => 10/182348 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7198 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133874.pdf [firstpage_image] =>[orig_patent_app_number] => 10182348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847391 [patent_doc_number] => 20030166558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response thereto' [patent_app_type] => new [patent_app_number] => 10/301488 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 34765 [patent_no_of_claims] => 115 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166558.pdf [firstpage_image] =>[orig_patent_app_number] => 10301488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843607 [patent_doc_number] => 20030148954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Agents and methods for modulating activator protein-1-mediated cellular processes' [patent_app_type] => new [patent_app_number] => 10/287196 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20947 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148954.pdf [firstpage_image] =>[orig_patent_app_number] => 10287196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696357 [patent_doc_number] => 20030108551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Methods and compositions of monoclonal antibodies specific for beta-amyloid proteins' [patent_app_type] => new [patent_app_number] => 10/288557 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11908 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108551.pdf [firstpage_image] =>[orig_patent_app_number] => 10288557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019401 [patent_doc_number] => 20050221420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Nogo receptor homologues and their use' [patent_app_type] => utility [patent_app_number] => 10/491810 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13878 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221420.pdf [firstpage_image] =>[orig_patent_app_number] => 10491810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818440 [patent_doc_number] => 20030069398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Identification of human gaba transporter' [patent_app_type] => new [patent_app_number] => 10/239566 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9198 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069398.pdf [firstpage_image] =>[orig_patent_app_number] => 10239566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766101 [patent_doc_number] => 20030100501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Q4N2NEG2 enhances CFTR activity' [patent_app_type] => new [patent_app_number] => 10/252012 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15285 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100501.pdf [firstpage_image] =>[orig_patent_app_number] => 10252012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779364 [patent_doc_number] => 20030050446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Regulation of human neuropeptide y-like g protein-coupled receptor' [patent_app_type] => new [patent_app_number] => 10/221662 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23632 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050446.pdf [firstpage_image] =>[orig_patent_app_number] => 10221662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355581 [patent_doc_number] => 20040048871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Use of high dose intravenous methotrexate, with leucovorin rescue, to treat early multiple sclerosis and other diseases of the central nervous system' [patent_app_type] => new [patent_app_number] => 10/237320 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2960 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048871.pdf [firstpage_image] =>[orig_patent_app_number] => 10237320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869971 [patent_doc_number] => 20030082660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Orthologues of human receptors and methods of use' [patent_app_type] => new [patent_app_number] => 10/237563 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9524 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082660.pdf [firstpage_image] =>[orig_patent_app_number] => 10237563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334132 [patent_doc_number] => 07507543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'GABAB receptor polypeptides and screening methods' [patent_app_type] => utility [patent_app_number] => 10/235463 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 11757 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507543.pdf [firstpage_image] =>[orig_patent_app_number] => 10235463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656595 [patent_doc_number] => 20030077740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Presenilin/Crk binding polypeptides (PCBP) and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/234961 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30410 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077740.pdf [firstpage_image] =>[orig_patent_app_number] => 10234961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740268 [patent_doc_number] => 20030157637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Diagnostics and treatments of periodontal disease' [patent_app_type] => new [patent_app_number] => 10/229066 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16184 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157637.pdf [firstpage_image] =>[orig_patent_app_number] => 10229066 [rel_patent_id] =>[rel_patent_doc_number] =>)